Journal article Open Access

FORMULATION DEVELOPMENT AND INVITRO EVALUATION OF RANOLAZINE EXTENDED RELEASE TABLETS

Alladi saritha and Rebecca Sanjana

The ranolazine extended release tablets can be prepared by wet granulation method using different polymers in varying combinations. Tablet blends were prepared and micromeritic studies were carried out for those blends and found to be within the limits. Compatability studies were carried out and found that drugs and excipients are compatible with each other. Post compression parameters were carried out found to be within the limits. Also dissolution data of all formulations reveals that as combination of Compritol, Carbopol934P increases the percentage drug release was found to be increased Formulation (F8) containing combination of Compritol, Carbopol934P shows that the 99.5% drug release was found in 24hrs and found similar with that of innovator. On comparing R2 with innovator, formulation (f8) shows similar results with marketed formulation Key words: ranolazine, extended release tablets, Compritol, Carbopol934P

Files (842.5 kB)
Name Size
92.saritha ranolazine.pdf
md5:19ec7b4609f09e9dbb2f8b26470fd21e
842.5 kB Download
7
31
views
downloads
All versions This version
Views 77
Downloads 3131
Data volume 26.1 MB26.1 MB
Unique views 77
Unique downloads 3030

Share

Cite as